Skip to content

LSD: all studies

Page 230 of 282: studies 2,291 to 2,300 of 2,815, newest first. Back to the LSD overview

Research

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe.

Frontiers in Pharmacology 2019 Cristina Miliano, Matteo Marti, Nicholas Pintori et al.

4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), commonly called "N-Bomb," is a synthetic phenethylamine with psychedelic and entactogenic effects; it was available on the Internet both as a legal alternative to lysergic acid diethylamide (LSD) and as a surrogate of 3,4-methylenedioxy-methamphetamine (MDMA), but now it has been scheduled among controlled substances. 25I-NBOMe...

Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton, and James W. Spark, eds., Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond, Reviewer: Robert Dickins

History of Pharmacy and Pharmaceuticals 2019 Robert Dickins

Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton, and James W. Spark, eds., Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond. Montreal: McGill-Queen’s University Press, 2018; 728 pp; 10 b&w images; ISBN: 9780773555068; cloth;

The Mushroom, the Frog, and the Rainbow of Desire: A Participatory-Psychedelic Spiritual Emergence

International Journal of Transpersonal Studies 2019

This article will explore a spiritual emergency through a myth or fairy tale that emerged at the same time I had a frightening brush with death. Two days before the accident I had ingested psilocybin mushrooms. Michael Washburn, among other transpersonal theorists, will be used to interpret, amplify and re-frame this potential ‘psychotic episode’ with ‘borderline features’ into something more,...

Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.

Journal of Psychoactive Drugs 2019 Erika Dyck 16 citations

This article examines the historical relationship between psychedelics and palliative care. Historians have contributed to a growing field of studies about how psychedelics have been used in the past, but much of that scholarship focused on interrogating questions of legitimacy or proving that psychedelics had therapeutic potential. Palliative care had not yet developed as medical...

DOI: 10.1080/02791072.2019.1581308 (opens in new tab) Full text (opens in new tab) Death and dying Medical humanities Palliative care Psychedelics +1

Rapid-acting antidepressants.

Advances in pharmacology (San Diego, Calif.) 2019 Jeffrey M. Witkin, Anna E Martin, Lalit K Golani et al. 71 citations

Conventional antidepressants (biogenic amine mechanisms) are not fully efficacious (e.g., symptoms remain after treatment, not all patients respond), produce effects only after weeks of daily dosing, and do not impact all disease symptoms. In contrast, a new class of antidepressants has been emerging since 2006 that has demonstrated rapid onset, large effect size, activity after only a single...

DOI: 10.1016/bs.apha.2019.03.002 (opens in new tab) Full text (opens in new tab) Ketamine Gabaa α5 Psychedelic drugs Rapid-acting antidepressants +2

Assessing novel expectancies about ayahuasca : a preliminary report

2019 Brianna R. Altman

Given the growing popularity of Ayahuasca, we sought to identify why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin. Experienced users (N=139) completed an online survey about their use of hallucinogens, including ayahuasca, how their ayahuasca experiences differed from those with other hallucinogens, and their willingness to use ayahuasca over...

Advances in Psychedelic Medicine

2019 17 citations

Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now...

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature

Therapeutic Advances in Psychopharmacology 2019 Juliana Mendes Rocha, Flávia de Lima Osório, José Alexandre S. Crippa et al. 44 citations

Background: Recognition of emotions in facial expressions (REFE) is a key aspect of social cognition. Anxiety and mood disorders are associated with deficits in REFE, and anxiolytics and antidepressants reverse these deficits. Recent studies have shown that serotonergic hallucinogens (i.e. ayahuasca, dimethyltryptamine, psilocybin, lysergic acid diethylamide [LSD], and mescaline) have...

Mapping the Boundaries between Science and Religion

transcript Verlag eBooks December 31, 2018 Stephanie Gripentrog-Schedel 3 citations

In contemporary religious landscapes, entanglements between the field of religion and the field of psychology and psychiatry are manifold.In this paper, the psychological school of "Transpersonal Psychology" (TP) and specifically the work of the psychiatrist and LSD researcher Stanislav Grof is introduced in order to illuminate the interferences between psychological or therapeutic discourses...

THE RECEPTION OF C.G. JUNG IN US DEATH AND DYING STUDIES

Phanês Journal For Jung History November 19, 2018 Jelena Martinovic 1 citation

C.G. Jung’s work has had a noticeable impact on conceptions about death and the dying experience, as well as on the therapeutic work methods that deal with anxiety, depression or terminal illnesses. This article analyses the reception of C.G. Jung’s work in the United States during the time period 1960-80. It examines ways in which Jung’s concepts were discussed and applied by psy practitioners...

DOI: 10.32724/phanes.2018.martinovic (opens in new tab) Mysticism Thanatology Psychoanalysis Transpersonal psychology +10